USFDA red flags Lupin for significant violations at MP unit

The USFDA said it had inspected the Unit 1 at the Mandideep facility of the company from November 26 to December 4, 2018.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2oLJLg5
via IFTTT